Cargando…

Immune-related adverse events: A bibliometric analysis

BACKGROUND: Despite providing clinical benefit, immune checkpoint inhibitors (ICIs) can cause immune-related adverse events (irAEs) in a number of patients. This study explored the development pattern in irAEs research from a bibliometric perspective. METHODS: We obtained articles and reviews relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shi-Tao, Liu, Yao-Ge, Zhang, Lei, Sang, Xin-Ting, Xu, Yi-Yao, Lu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797501/
https://www.ncbi.nlm.nih.gov/pubmed/36591239
http://dx.doi.org/10.3389/fimmu.2022.1096806
_version_ 1784860694035824640
author Jiang, Shi-Tao
Liu, Yao-Ge
Zhang, Lei
Sang, Xin-Ting
Xu, Yi-Yao
Lu, Xin
author_facet Jiang, Shi-Tao
Liu, Yao-Ge
Zhang, Lei
Sang, Xin-Ting
Xu, Yi-Yao
Lu, Xin
author_sort Jiang, Shi-Tao
collection PubMed
description BACKGROUND: Despite providing clinical benefit, immune checkpoint inhibitors (ICIs) can cause immune-related adverse events (irAEs) in a number of patients. This study explored the development pattern in irAEs research from a bibliometric perspective. METHODS: We obtained articles and reviews related to irAEs from the Web of Science Core Collection (WoSCC) (retrieved on September 13, 2022). Using the R package “Bibliometrix”, the main bibliometric features were calculated, and a three-filed plot was generated to show the relationship between authors, institutions, and topics. VOSviewer was used for co-authorship and keyword co-occurrence analysis and visualization. CiteSpace was used to detect burst references and keywords. RESULTS: A total of 3995 publications on irAEs were included. The United States (US), Japan, and China had the highest publications. The Journal for ImmunoTherapy of Cancer had the highest number of publications. In addition to “immune-related adverse events”, “immune checkpoint inhibitors”, “immunotherapy”, and “nivolumab” were the most frequently used keywords. CONCLUSIONS: A bibliometric analysis of 17 years of irAEs research was conducted to map a basic knowledge structure including countries, institutions, authors, journals, and publications. The findings provided a comprehensive perspective on the broad future of this research area.
format Online
Article
Text
id pubmed-9797501
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97975012022-12-30 Immune-related adverse events: A bibliometric analysis Jiang, Shi-Tao Liu, Yao-Ge Zhang, Lei Sang, Xin-Ting Xu, Yi-Yao Lu, Xin Front Immunol Immunology BACKGROUND: Despite providing clinical benefit, immune checkpoint inhibitors (ICIs) can cause immune-related adverse events (irAEs) in a number of patients. This study explored the development pattern in irAEs research from a bibliometric perspective. METHODS: We obtained articles and reviews related to irAEs from the Web of Science Core Collection (WoSCC) (retrieved on September 13, 2022). Using the R package “Bibliometrix”, the main bibliometric features were calculated, and a three-filed plot was generated to show the relationship between authors, institutions, and topics. VOSviewer was used for co-authorship and keyword co-occurrence analysis and visualization. CiteSpace was used to detect burst references and keywords. RESULTS: A total of 3995 publications on irAEs were included. The United States (US), Japan, and China had the highest publications. The Journal for ImmunoTherapy of Cancer had the highest number of publications. In addition to “immune-related adverse events”, “immune checkpoint inhibitors”, “immunotherapy”, and “nivolumab” were the most frequently used keywords. CONCLUSIONS: A bibliometric analysis of 17 years of irAEs research was conducted to map a basic knowledge structure including countries, institutions, authors, journals, and publications. The findings provided a comprehensive perspective on the broad future of this research area. Frontiers Media S.A. 2022-12-15 /pmc/articles/PMC9797501/ /pubmed/36591239 http://dx.doi.org/10.3389/fimmu.2022.1096806 Text en Copyright © 2022 Jiang, Liu, Zhang, Sang, Xu and Lu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Jiang, Shi-Tao
Liu, Yao-Ge
Zhang, Lei
Sang, Xin-Ting
Xu, Yi-Yao
Lu, Xin
Immune-related adverse events: A bibliometric analysis
title Immune-related adverse events: A bibliometric analysis
title_full Immune-related adverse events: A bibliometric analysis
title_fullStr Immune-related adverse events: A bibliometric analysis
title_full_unstemmed Immune-related adverse events: A bibliometric analysis
title_short Immune-related adverse events: A bibliometric analysis
title_sort immune-related adverse events: a bibliometric analysis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797501/
https://www.ncbi.nlm.nih.gov/pubmed/36591239
http://dx.doi.org/10.3389/fimmu.2022.1096806
work_keys_str_mv AT jiangshitao immunerelatedadverseeventsabibliometricanalysis
AT liuyaoge immunerelatedadverseeventsabibliometricanalysis
AT zhanglei immunerelatedadverseeventsabibliometricanalysis
AT sangxinting immunerelatedadverseeventsabibliometricanalysis
AT xuyiyao immunerelatedadverseeventsabibliometricanalysis
AT luxin immunerelatedadverseeventsabibliometricanalysis